Positron emission tomography (PET) could prove to be a better imaging procedure than magnetic resonance imaging (MRI) in the detection of glioblastoma, the most aggressive type of primary brain tumor.  Funded by a Cancer Council WA grant of more than $143,000, researchers at the University of WA’s School of Medicine and Pharmacology are testing a new PET imaging agent that collects in high levels in glioma cells but low levels in normal brain tissue. {read more here}